Evidence map›Paper›PMID 42742156›Full record

ArticleEndocrine-related cancer2026

STING expression in pituitary neuroendocrine tumour immune microenvironments.

Paul Benjamin Loughrey, Aoife McArdle, Amélie Viratham Pulsawatdi, Kris D McCombe, Christine Greene, Hannah James, Estelle G Healy, Fionn Corr, Ella Ross, Stephen Cooke and 4 more

Abstract read
In one paragraph

Article in Endocrine-related cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Paul Benjamin LoughreyJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.ORCID 0000-0002-5491-6730
Aoife McArdleJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Amélie Viratham PulsawatdiJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Kris D McCombeJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Christine GreeneNorthern Ireland Biobank, Future Medicines Institute, Queen's University Belfast , Belfast, United Kingdom.
Hannah JamesJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Estelle G HealyDepartment of Cellular Pathology, Belfast Health and Social Care Trust , Belfast, United Kingdom.ORCID 0000-0002-3463-1068
Fionn CorrJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Ella RossJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.
Stephen CookeDepartment of Neurosurgery, Belfast Health and Social Care Trust , Belfast, United Kingdom.
Steven J HunterRegional Centre for Endocrinology and Diabetes, Belfast Health and Social Care Trust , Belfast, United Kingdom.ORCID 0000-0001-5737-6250
Márta KorbonitsDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London , London, United Kingdom.ORCID 0000-0002-4101-9432
Stephanie G CraigJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.ORCID 0000-0002-5476-751X
Jacqueline A JamesJohnston Cancer Research Centre, Queen's University Belfast, Queen's University Belfast , Belfast, United Kingdom.ORCID 0000-0002-6945-6060

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pituitary neuroendocrine tumour (PitNET) immune microenvironment (IME) has become a recent focus of research interest. Multiplex immunofluorescence combined with digital image analysis is a powerful technique to interrogate the IME. Processes such as DNA damage response and cellular senescence have been implicated in somatotroph tumour pathogenesis, and these have in turn been linked with immunological responses to neoplasia. The objectives of this study were to compare the immune cell infiltrate in PitNETs to normal pituitary, investigate how the PitNET-IME may vary according to treatment with somatostatin receptor ligand, tumour invasiveness, tumour proliferation, and AIP mutation status. Two bespoke multiplex panels were developed and applied to a range of PitNET subtypes before being interrogated with deep learning algorithms and QuPath image analysis software. Tumours had significantly higher total macrophage infiltrate (P < 0.001), STING+ macrophages (P < 0.001) and STING positivity (P < 0.001) compared with normal pituitary tissue. Macrophage infiltration and STING positivity were positively correlated with tumour Ki-67 proliferation index (rs = 0.305, P = 0.003; and rs = 0.263, P = 0.010, respectively). Results suggested that AIP-mutated PitNETs may have higher CD8+ T-lymphocyte infiltrate, macrophage infiltrate, including STING+ macrophages and overall STING positivity compared with AIP-negative tumours. The application of machine learning to multiplex immunofluorescence images identifies macrophages and STING as upregulated in these subgroups of functioning PitNETs. This immunological response may indicate that DNA damage, cellular senescence and autophagy could be features of these tumours.

Indexed as

Membrane ProteinsNeuroendocrine TumorsPituitary NeoplasmsTumor MicroenvironmentFemaleHumansMaleSTING ProteinMembrane ProteinsSTING ProteinAIPdigital pathologymultiplex immunofluorescencepituitarySTINGtumour immune microenvironment

Identifiers

PMID42742156
PMCPMC13641126

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.